CONFERENCE UPDATE: AAAAI 2022
Lower type 2 inflammation biomarkers in adult and adolescent EoE patients treated with dupilumab
30 Mar 2022
CONFERENCE UPDATE: AAAAI 2022
Lower type 2 inflammation biomarkers in adult and adolescent EoE patients treated with dupilumab